Recently, a study on the metabolism in pancreatic cancer has demonstrated that pancreatic cancer cells rely on the distinct pathway in which glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway [57]. The gene discussed is KRAS; the disease is pancreatic neoplasm.